Thunder Mountain Gold (OTCMKTS:THMG) and Lexaria Bioscience (NASDAQ:LEXX) are both small-cap basic materials companies, but which is the superior business? We will compare the two companies based on the strength of their risk, profitability, dividends, institutional ownership, valuation, earnings and analyst recommendations.
Analyst Recommendations
This is a breakdown of recent ratings and price targets for Thunder Mountain Gold and Lexaria Bioscience, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
|---|
| Thunder Mountain Gold | 0 | 0 | 0 | 0 | N/A |
| Lexaria Bioscience | 0 | 0 | 0 | 0 | N/A |
Profitability
This table compares Thunder Mountain Gold and Lexaria Bioscience's net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
|---|
| Thunder Mountain Gold | 211.50% | 182.13% | 65.01% |
| Lexaria Bioscience | -1,046.77% | -157.62% | -148.09% |
Insider & Institutional Ownership
0.1% of Lexaria Bioscience shares are owned by institutional investors. 29.5% of Thunder Mountain Gold shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Earnings & Valuation
This table compares Thunder Mountain Gold and Lexaria Bioscience's top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
|---|
| Thunder Mountain Gold | $1.95 million | 4.87 | $1.08 million | N/A | N/A |
| Lexaria Bioscience | $380,000.00 | 83.14 | $-4,090,000.00 | N/A | N/A |
Thunder Mountain Gold has higher revenue and earnings than Lexaria Bioscience.
Summary
Thunder Mountain Gold beats Lexaria Bioscience on 6 of the 8 factors compared between the two stocks.
